Skip to main content

Thomas Roberts Kinney, MD

Wilburt C. Davison Professor of Pediatrics, in the School of Medicine
Professor of Pediatrics
Associate Chair, Department of Pediatrics
Campus mail: 0901 Childrens Hlth Ctr, Durham, NC 27710
Phone: (919) 681-4443
Email address: kinne001@mc.duke.edu

For the past 15 years, Thomas R. Kinney, MD has focused his clinical research efforts on sickle cell. He has been a leader in the NIH funded multi-institutional collaborative study that began in 1978 to define the natural history of sickle cell disease. He also has played a pivotal role in the implementation and monitoring of the North Carolina Neonatal Hemoglobinopathy Screening Program. In 1993, he served as Co-Chairman of a Federal Panel convened by the Agency for Health Care Policy and Research to develop guidelines for sickle cell screening programs.

Dr. Kinney currently serves as the Associate Chairman Emeritus of the Department of Pediatrics.

Education and Training

  • M.D., Duke University, 1970

Publications

Kinney, T. R., R. W. Helms, E. E. O’Branski, K. Ohene-Frempong, W. Wang, C. Daeschner, E. Vichinsky, et al. “Safety of hydroxyurea in children with sickle cell anemia: results of the HUG-KIDS study, a phase I/II trial. Pediatric Hydroxyurea Group..” Blood 94, no. 5 (September 1999): 1550–54.

Scholars@Duke

Beyer, J. E., A. F. Platt, T. R. Kinney, and M. Treadwell. “Practice guidelines for the assessment of children with sickle cell pain..” J Soc Pediatr Nurs 4, no. 2 (April 1999): 61–73.

Scholars@Duke

Kinney, T. R., L. A. Sleeper, W. C. Wang, R. A. Zimmerman, C. H. Pegelow, K. Ohene-Frempong, D. L. Wethers, et al. “Silent cerebral infarcts in sickle cell anemia: a risk factor analysis. The Cooperative Study of Sickle Cell Disease..” Pediatrics 103, no. 3 (March 1999): 640–45. https://doi.org/10.1542/peds.103.3.640.

Full Text

Adams, D. M., R. E. Ware, W. H. Schultz, A. K. Ross, K. T. Oldham, and T. R. Kinney. “Successful surgical outcome in children with sickle hemoglobinopathies: the Duke University experience..” J Pediatr Surg 33, no. 3 (March 1998): 428–32. https://doi.org/10.1016/s0022-3468(98)90083-5.

Full Text

Woods, G. M., J. H. Jorgensen, M. A. Waclawiw, C. Reid, W. Wang, C. H. Pegelow, Z. R. Rogers, et al. “Influence of penicillin prophylaxis on antimicrobial resistance in nasopharyngeal S. pneumoniae among children with sickle cell anemia. The Ancillary Nasopharyngeal Culture Study of Prophylactic Penicillin Study II..” Journal of Pediatric Hematology/Oncology 19, no. 4 (July 1997): 327–33. https://doi.org/10.1097/00043426-199707000-00011.

Full Text

Gil, K. M., J. L. Edens, J. J. Wilson, L. B. Raezer, T. R. Kinney, W. H. Schultz, and C. Daeschner. “Coping strategies and laboratory pain in children with sickle cell disease..” Ann Behav Med 19, no. 1 (1997): 22–29. https://doi.org/10.1007/BF02883423.

Full Text

Winter, S. S., T. R. Kinney, E. E. O’Branski, and R. E. Ware. “Evaluation and management of acute neurologic symptoms in children with sickle cell disease.” International Journal of Pediatric Hematology/Oncology 4, no. 4 (January 1, 1997): 339–46.

Scholars@Duke

Marcus, S. J., T. R. Kinney, W. H. Schultz, E. E. O’Branski, and R. E. Ware. “Quantitative analysis of erythrocytes containing fetal hemoglobin (F cells) in children with sickle cell disease..” Am J Hematol 54, no. 1 (January 1997): 40–46. https://doi.org/10.1002/(sici)1096-8652(199701)54:1<40::aid-ajh6>3.0.co;2-4.

Full Text

Bjornson, A. B., J. M. Falletta, J. I. Verter, G. R. Buchanan, S. T. Miller, C. H. Pegelow, R. V. Iyer, et al. “Serotype-specific immunoglobulin G antibody responses to pneumococcal polysaccharide vaccine in children with sickle cell anemia: effects of continued penicillin prophylaxis..” J Pediatr 129, no. 6 (December 1996): 828–35. https://doi.org/10.1016/s0022-3476(96)70026-4.

Full Text

Kinney, T. R., and R. E. Ware. “The adolescent with sickle cell anemia..” Hematol Oncol Clin North Am 10, no. 6 (December 1996): 1255–64.

Scholars@Duke

Pages